Raymond Kwong, M.D., MPH, from the Harvard Medical School recently presented his findings on a study of how single-center stress cardiovascular magnetic resonance (CMR) research studies have shown excellent values in management of patients with suspected ischemia. Kwong, who is also a member of the Society for Cardiovascular Magnetic Resonance (SCMR) presented his findings at the 2018 European Society of Cardiology (ESC) Congress, Aug. 25-29 in Munich, Germany.

September 17, 2018 — The Ohio State University Wexner Medical Center in Columbus recently became the first healthcare ...

In February 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Maryland, to explore ...

A new Phase 2 clinical trial looks to confirm the efficacy and safety of Thrombolytic Science LLC’s (TSI) sequential dual-treatment regimen of low-dose tissue plasminogen activator (tPA) and HisproUK (TSI’s mutant prourokinase [proUK]) in ischemic stroke patients. The study follows a recently completed Phase 1 study that confirmed the safety and tolerability of TSI’s regimen in healthy volunteers (n=26).

While it is firmly established that the use of one internal thoracic artery can improve life expectancy in coronary artery bypass graft (CABG) surgery compared to vein grafts, it is not known if there are additional benefits with the use of a second artery. This was explored in the ten-year outcomes of the Arterial Revascularisation Trial (ART) presented in a Hot Line Session at the European Society of Cardiology (ESC) Congress 2018, Aug. 25-28 in Munich, Germany.